A338220 Stock Overview
Operates as a medical artificial intelligence (AI) solution development company.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Vuno Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩27,750.00 |
| 52 Week High | ₩69,500.00 |
| 52 Week Low | ₩23,900.00 |
| Beta | 1.67 |
| 11 Month Change | -2.46% |
| 3 Month Change | -13.15% |
| 1 Year Change | -13.15% |
| 33 Year Change | 19.61% |
| 5 Year Change | n/a |
| Change since IPO | -13.69% |
Recent News & Updates
Is Vuno Inc. (KOSDAQ:338220) Trading At A 42% Discount?
May 20
After Leaping 30% Vuno Inc. (KOSDAQ:338220) Shares Are Not Flying Under The Radar
Mar 13Vuno (KOSDAQ:338220) Has Debt But No Earnings; Should You Worry?
Mar 01Shareholder Returns
| A338220 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 4.5% | -7.1% | -0.01% |
| 1Y | -13.1% | 7.0% | 5.0% |
Return vs Industry: A338220 underperformed the KR Medical Equipment industry which returned 7% over the past year.
Return vs Market: A338220 underperformed the KR Market which returned 5% over the past year.
Price Volatility
| A338220 volatility | |
|---|---|
| A338220 Average Weekly Movement | 7.4% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.1% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A338220 has not had significant price volatility in the past 3 months.
Volatility Over Time: A338220's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 142 | n/a | www.vuno.co |
Vuno Inc. operates as a medical artificial intelligence (AI) solution development company. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. Its products include BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalities in the fundus of the eye; and LungCT AI, an AI-based pulmonary lung nodule detection and reporting system.
Vuno Inc. Fundamentals Summary
| A338220 fundamental statistics | |
|---|---|
| Market cap | ₩385.40b |
| Earnings (TTM) | -₩15.24b |
| Revenue (TTM) | ₩17.04b |
22.6x
P/S Ratio-25.3x
P/E RatioIs A338220 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A338220 income statement (TTM) | |
|---|---|
| Revenue | ₩17.04b |
| Cost of Revenue | ₩1.02b |
| Gross Profit | ₩16.02b |
| Other Expenses | ₩31.26b |
| Earnings | -₩15.24b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.10k |
| Gross Margin | 94.02% |
| Net Profit Margin | -89.47% |
| Debt/Equity Ratio | 82.0% |
How did A338220 perform over the long term?
See historical performance and comparison